While the White House and doctors at Walter Reed have sought to reassure the public that Trump's condition is improving, he has received numerous drugs for Covid-19, including the steroid dexamethasone, which is typically administered only to those who are critically ill.
The WHO's REACT Working Group published an analysis of seven trials of dexamethasone, hydrocortisone and methylprednisolone in the Journal of the American Medical Association Wednesday, finding a lower rate of all-cause mortality at 28 days among critically ill patients receiving the drugs.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Data from a large Phase II/III study in the U.K. showed that patients requiring respiratory support who received the drug dexamethasone died at lower rates than those who received standard treatments alone.